| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |